Skip to content

Federal opportunity · Special Notice

FY27 FDA Broad Agency Announcement (BAA) for Advanced Research and Development of Regulatory Science

FDABAA-27-00123 · Health and Human Services, Department of · SAM.gov

! Responses due Feb 1, 2027, 5:00 PM ET · 87 days left

Responses due
Feb 1, 2027, 5:00 PM ET
Posted
Oct 30, 2026
NAICS code
541714 · Research and Development in Biotechnology (except Nanobiotechnology)
Set-aside
None
Place of performance
Not listed
Notice type
Special Notice
Solicitation number
FDABAA-27-00123
Official notice
View on SAM.gov →

What the agency is buying

In accordance with FAR 6.102(d)(2) and 35.016, the US Food and Drug Administration (FDA) solicits for the acquisition of basic and applied research and development proposals to support regulatory science and innovation through this Broad Agency Announcement (BAA). Research and development activities acquired under this BAA are intended to advance scientific knowledge in specific research areas as well as sub areas of interest defined within the BAA that serve the FDA in accomplishing its mission to protect and promote the health of our nation. Proposals submitted under this announcement are not limited solely to the PSC code "AJ11" specified in this announcement. FDA funds extramural research through an agency-wide Broad Agency Announcement (BAA) for research and development to support regulatory science and innovation.

From the official notice on SAM.gov.

See if this one is a Go for your company. Get your score →

Similar open opportunities

See every open one, scored for your company →